Conatus Pharmaceuticals Inc.·4

Jul 1, 4:34 PM ET

LARUE WILLIAM R 4

4 · Conatus Pharmaceuticals Inc. · Filed Jul 1, 2019

Insider Transaction Report

Form 4
Period: 2019-06-27
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-06-27+20,00020,000 total
    Exercise: $0.29Exp: 2029-06-26Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option become exercisable as the shares vest. The entire number of shares subject to this option becomes fully vested and exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION